Member access

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

Research and Markets: Swedish Telecommunications Report 2013

10/07/2013 | 05:53am US/Eastern
Recommend:
0

Research and Markets (http://www.researchandmarkets.com/research/wr68gx/telecommunications) has announced the addition of the "Telecommunications (Sweden)" report to their offering.

This report (compiled in English language) includes a wealth of information on the financial trends over the past four years. This, the latest telecommunications analysis, is ideal for anyone wanting to:

  • See the market leaders
  • Identify companies heading for failure
  • Seek out the most attractive acquisition
  • Analyse industry trends
  • Benchmark their own financial performance

Using exclusive methodology, a quick glance of this report will tell you that 31 companies have a declining financial rating, while 36 have shown good sales growth.

Each of the largest 150 companies is meticulously scrutinised in a one-page individual assessment and is analysed using the most up-to-date and current financial data.

Every business is examined on the following features:

  • A graphical assessment of a company's financial performance
  • Four year assessment of the profit/loss and balance sheet
  • A written summary highlighting key performance issues

Subsequently, you will receive a thorough market analysis highlighting the latest changes in the market.

This section includes:

  • Best Trading Partners
  • Sales Growth Analysis
  • Profit Analysis
  • Market Size
  • Rankings

Key Topics Covered:

The report (compiled in English language) is split into two sections and uses both a written and graphical analysis - analysing the 150 largest companies.

It also contains the most-up-to-date financial data and applies these figures to create their unique and authoritative analysis.

The next section focuses on company analysis and provides an in-depth analysis of the largest companies within the industry.

Each business is analysed using an unequivocal model which uses a series of charts to graphically analyse an individual company and measure its ability to achieve sales growth while maintaining financial strength.

Therefore, this company analysis will tell you if a company is:

  • Strong or heading for failure
  • Utilising their investments
  • Becoming burdened by debt
  • Getting the most from their resources

The analysis also provides you with full business name and address, name and ages of directors and registration address.

For more information visit http://www.researchandmarkets.com/research/wr68gx/telecommunications

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Computing


© Business Wire 2013
Recommend :
0
React to this article
Latest news
Date Title
1m agoDJAustralia 2Q Current Account Deficit Widens
3m agoDJAustralian Home-Building Approvals Rise
3m agoDJObama to Reassure Baltic States Worried About Russia
3m ago SSANGYONG MOTOR : New Actyon launch in Colombia
7m ago Australia government spending dips 0.6 percent in second quarter
9m agoDJAustralian Home-Building Approvals Rise
9m agoDJAustralian Home-Building Approvals Rise
18m ago ORCA EXPLORATION : announces Q2 2014 results
19m ago Japanese regular pay and bonuses rise in July, offer relief for PM Abe
23m ago EUR/USD TECHNICAL ANALYSIS : Euro Sinks to One-Year Low
Latest news
Advertisement
Hot News 
FORBIDDEN TECHNOLOGIES : Launches Alpha Test Of 'Eva' Video Platform
PERFORM : Final cash offer
WORTHINGTON : Re Agreement
SEEING MACHINES : Trading Up 25% As It Teams With Takata Corp
SHANTA GOLD : Reaffirms Production Guidance As First-Half Profit Rises
Most Read News
3h ago FORMFACTOR : Raises Third Quarter Guidance Range
3h ago STUART OLSON : announces sale of Broda Construction
3h ago EXELIXIS : Announces Results from the COMET-1 Phase 3 Pivotal Trial of Cabozantinib in Men with Metastatic Castration-Resistant Prostate Cancer
2h ago MEDICINOVA : to Present Data on MN-001 (tipelukast) for the Treatment of Idiopathic Pulmonary Fibrosis (IPF) During the 18th International Colloquium on Lung and Airway Fibrosis (ICLAF)
2h ago Akzo Nobel CEO solicited for Axalta bid worth more than $7 billion - Bloomberg
Most recommended articles
14h agoDJZambia Copper Miners Say Crippled by Unpaid $600 Million Tax Refund-Mines Body
3d ago S&P 500 edges up to set new record; best month since Feb
1m agoDJAustralia 2Q Current Account Deficit Widens
2m agoDJAustralian Home-Building Approvals Rise
3m agoDJObama to Reassure Baltic States Worried About Russia
Dynamic quotes  
ON
| OFF